Ignite Creation Date:
2024-05-05 @ 7:06 PM
Last Modification Date:
2024-10-26 @ 9:43 AM
Study NCT ID:
NCT00604552
Status:
TERMINATED
Last Update Posted:
2021-10-29
First Post:
2007-12-21
Brief Title:
AneuRx Post Market Study in the Treatment of AAA
Sponsor:
Medtronic Cardiovascular
Organization:
Medtronic Cardiovascular
Study Overview
Official Title:
AneuRx Post Market Surveillance Registry
Status:
TERMINATED
Status Verified Date:
2021-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Mutual agreement between FDA closed the 522 postmarket surveillance Registry
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aorta is a large blood vessel that carries blood away from the heart to the organs in the rest of the body An aneurysm is a weakening in the artery wall that will become a bulge in the aorta If left untreated this bulge may continue to grow larger and may rupture break open with fatal consequences Abdominal aortic aneurysm AAA is a life-threatening lesion that has been treated in recent year via endovascular repair
The purpose of this study is to monitor the long term performance of the AneuRx Stent Graft Systems
The purpose of this study is to monitor the long term performance of the AneuRx Stent Graft Systems
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None